CAL
GOSS icon

Capital Advisors Ltd’s Gossamer Bio GOSS Stock Holding History

Capital Advisors Ltd’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17
Closed – – 1460
2025
Q4 		$0 Hold
17
– – ﹤0.01% 1437
2025
Q3 		$0 Hold
17
– – ﹤0.01% 1439
2025
Q2 		$0 Hold
17
– – ﹤0.01% 1453
2025
Q1 		$0 Hold
17
– – ﹤0.01% 1437
2024
Q4 		$0 Sell
17
-124
-88% -$106 ﹤0.01% 1463
2024
Q3 		$0 Sell
141
-65
-32% -$63 ﹤0.01% 1476
2024
Q2 		$0 Buy
206
+150
+268% +$112 ﹤0.01% 1492
2024
Q1 		$0 Buy
+56
New +$62 ﹤0.01% 1433
2023
Q4 		– Sell
-208
Closed – – 1369
2023
Q3 		$0 Buy
+208
New +$240 ﹤0.01% 1356

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Capital Advisors Ltd's GOSS Position: Q1 2026 in Review

Capital Advisors Ltd sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 17 shares.

Capital Advisors Ltd first reported a position in GOSS in Q3 2023 and held it in 9 quarters. The position peaked at $0 in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Capital Advisors Ltd reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Capital Advisors Ltd sold 17 Gossamer Bio shares in Q1 2026.
  • Capital Advisors Ltd first reported a position in Gossamer Bio in Q3 2023 and held it in 9 quarters.
  • Capital Advisors Ltd's Gossamer Bio position peaked at $0 in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Capital Advisors Ltd's 13F filing for Q1 2026, filed 16 Apr 2026.